In mixed-species communities, bacteria can deploy contact-dependent effectors to compete with other organisms, often directly injecting these proteins into neighboring cells. One current hypothesis is that the entire protein contains information specific for a single 20 species; emergence of new effectors comes from acquiring genes. Here we have characterized a family of DNA-degrading effectors that are nucleases which cause death. Like other families of chimeric nucleases, these effectors contain two domains. One is a PD-(D/E)XK-containing domain necessary for DNA cleavage. The other domain, which does not contain known DNA-binding structures, encodes species-identifying information. 25 We capitalized on the species-identifying domain to differentiate among low-abundance species, as well as to reveal domain architectures within these proteins, in human gut and oral microbiomes. Emerging are questions about how low-abundance strains use effectors for survival and how strain-identifying effectors evolve.
Introduction
Bacteria within communities compete for resources. One strategy is to inject lethal effectors into adjacent cells; clonal siblings survive by neutralizing the effector while all other cells die (1) (2) (3) . Such bacterial effectors, which can act in many ways such as disrupt cell membranes and degrade proteins or nucleic acid (4) , are particularly useful for bacteria in gut 5 microbiomes and other mixed communities. Individual strains of a single species can encode different effectors, each with different structures (5) (6) (7) . Abundant species use their specific effectors to dominate in a mixed-species community (8, 9) . Yet low-abundance bacteria can remain successful residents within mixed-species communities that have a dominant strain; this mechanism for survival remains unclear. Moreover, strain-specific proteins could provide a 10 genome-encoded mechanism to differentiate among closely related bacteria.
The swarming bacterium Proteus mirabilis, a human opportunistic pathogen, is one of the low-abundance bacteria in some human guts. In P. mirabilis, the gene idrD, encoding a contactdependent lethal effector, was identified in a screen for self versus non-self recognition (10).
Strains lacking a functional idrD gene are unable to merge colonies with their wild-type parent 15 or dominate in mixed migrating populations (10) and possibly in the human host (11). IdrD is exported by a Type VI secretion system, allowing for transport through direct physical contact with adjacent cells (10, 12) . The C-terminal end of IdrD encodes a potential cell-contact dependent effector protein, IdrD-CT.
Polymorphic effectors like IdrD contain regions with known functions: the N-terminal 20 domain aids in the export via Types IV, V, or VI secretion systems (1, 13, 14) and the C-terminal domain often contains the lethal effector (2, 3, 7, 15) . For example, the well-established polymorphic effectors RhsA and RhsB have their enzymatic nuclease domains at the C-terminus; putative proteolytic cleavage results in the smaller effectors, RhsA-CT and RhsB-CT, respectively (2, 16) . Interestingly, effectors with similar functions, such as degrading DNA, can be of different protein families, each with distinct secondary and tertiary structures. This domain architecture could promote the existence of species-identifying effectors, leading to a hypothesis that the effector, encoded within the entire C-terminal domain, encodes specificity for a species 5 (17) . However, we found that proteins with similarity to IdrD-CT contained more sequence variation than could be explained by this hypothesis.
The uncharacterized IdrD-CT protein was particularly interesting because secondary and tertiary structure analysis predicted the presence of a PD-(D/E)XK motif, which is found in a broad superfamily of nucleases. Contact-dependent effectors in Burkholderia pseudomallei that 10 degrade tRNA (18) are an example of such nucleotide-targeting enzymes. Database searches revealed additional proteins with similarity to IdrD-CT, yet none of these proteins belonged to known families of the PD-(D/E)XK nuclease superfamily. Even though proteins containing the PD-(D/E)XK motif are found in animals, plants, and bacteria (19) , predicting the nucleotide target from the amino acid sequences remains difficult. Finding and characterizing additional 15 families is critical for developing algorithms that could predict function from sequence.
As such, we sought to characterize the function and nucleotide target of the IdrD-CT protein. Through biochemical assays, we found that IdrD-CT, and proteins with similar sequences, form a distinct family of PD-(D/E)XK nuclease proteins. We next investigated whether one could differentiate between low and high abundance bacteria in human datasets by 20 adapting metagenomics methods to find IdrD-CT. Metagenomes are short-read DNA datasets generated from all bacteria within a sampled community or microbiome. An adapted metagenomic analysis revealed that members of the IdrD-CT protein family are rare in human oral and gut microbiomes, even though the full-length encoding gene, idrD, is not. Analysis of metagenomes also showed that IdrD-CT proteins have an architecture with two separate domains, one encoding deoxyribonuclease (DNase) activity and the other with speciesidentifying sequences. IdrD-CT has a conserved cleavage action in the DNase domain and is flexible to amino acid changes, including entire domain replacements, in the species-identifying 5 domain. Species-identifying effectors could provide a means to differentiate among bacterial species within gut and oral microbiome datasets. The domain architecture of the IdrD-CT protein and related proteins raise questions about how strain-specific effectors evolve and how bacteria might deploy these effectors for survival at low abundance.
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Results
We found that the IdrD-CT proteins degrade DNA and form a family of PD-(D/E)XK proteins. P. mirabilis strain BB2000 needs the IdrD-CT protein to outcompete in mixed-strain populations (10), yet the protein had an unknown activity. We found a potential PD-(D/E)XK domain (1 -86 amino acids) residing in the N-terminal region. PD-(D/E)XK-containing proteins 15 can function in DNA repair, restriction, replication, or tRNA-intron splicing (19, 20) . We thus hypothesized that IdrD-CT might be a nucleotide-targeting protein.
If this hypothesis was correct, then IdrD-CT should prevent cell growth. Further, mutation of the PD-(D/E)XK catalytic site should disrupt the protein activity. In support of these predictions, we found that P. mirabilis cells engineered to overproduce IdrD-CT had 1000 fewer 20 cells per mL than cells not overproducing this protein ( Fig. 1A ). An equivalent growth pattern occurs in Escherichia coli cells engineered to overproduce the P. mirabilis IdrD-CT ( Fig. S1A ), indicating that the target is common among these bacteria. Three residues in the catalytic site (D, D/E, and K) are essential for nuclease function in PD-(D/E)XK-containing proteins (21, 22) . We replaced each residue in IdrD-CT (D39, E53, and K55) with an alanine residue individually and all at once. P. mirabilis producing these mutant proteins grew to a density equal to that of the negative control lacking IdrD-CT ( Fig. 1A) , indicating that these residues are essential for preventing cell growth. We concluded that IdrD-CT is a PD-(D/E)XK-containing protein. 5 Experimental determination of IdrD-CT's nucleotide target was necessary as predicting the nucleotide target from the amino acid sequence is still difficult for the PD-(D/E)XK nuclease superfamily. Imaging of wild-type P. mirabilis producing excess IdrD-CT from a vector showed an accumulation of misshapen cells with frequent absence of DNA ( Fig. 1B) . By contrast, control samples with no produced protein had characteristic elongated P. mirabilis cells; 10 fluorescence associated with DNA was regularly spaced along the length of the cells (Fig. 1B ).
E. coli cells producing IdrD-CT also had a morphology consistent with DNA damage or stress; cells were elongated and had irregular subcellular localizations of DAPI-stained DNA ( Fig.   S1B ). By contrast, E. coli cells without IdrD-CT were short with visible DAPI-stained DNA ( Fig. S1B ). Fluorescence due to DAPI was spaced regularly within each elongated cell of E. coli 15 producing the null mutant IdrD-CTD39A ( Fig. S1B ), indicating that disruption of the predicted active site in IdrD-CT prevents DNA disruption in these cells.
Fig. 1. IdrD-CT is a DNA-degrading enzyme in the PD-(D/E)XK superfamily. (A)
Displayed are colony-forming units per mL (CFU/mL) for P. mirabilis cells after excess production of GFP (negative control), IdrD-CT or mutant variants, as denoted. Protein is produced from a plasmid. (B) The micrographs show P. mirabilis grown on a swarm-permissive surface. IdrD-CT is P. 5 mirabilis overproducing the wild-type protein from a plasmid. The negative control is P. mirabilis with an equivalent empty vector; healthy P. mirabilis cells elongate in swarms. Left, Phase. Right, fluorescence of DAPI-stained DNA. (C) IdrD-CT-FLAG or IdrD-CTD39A-FLAG (2.5, 5 and 10 ng) were added to methylated and unmethylated lambda DNA (48,502 base pairs, bp), and assayed on an agarose gel with a 2-log DNA ladder. Only samples with IdrD-CT show 10 reduction in DNA. (D) Proteins like IdrD-CT are aligned (using MUSCLE) with predicted secondary structures as colors on top, generated using (23). Red are alpha-helices, and blue are beta-sheets; color intensity reflects confidence of the predictions. The PD-(D/E)XK domain is noted. An arrow marks the IdrD-CT from P. mirabilis strain BB2000. (E) Rothia IdrD-CT-FLAG and Rothia IdrD-CTD39A-FLAG (2.5, 5 and 10 ng) was added to lambda DNA and assayed as in (C). 15 Samples with Rothia IdrD-CT show a reduction in DNA.
The microscopy results implicated DNA as a likely target for IdrD-CT. To assess this possibility, we made IdrD-CT protein (~ 17 kDa) and the null mutant protein, IdrD-CTD39A, each containing a FLAG epitope tag for detection, in a cell-free extract and then introduced phage lambda DNA. Degradation of lambda DNA occurred in the presence of IdrD-CT, regardless of the DNA methylation state (Fig. 1C, Fig. S1C ). However, the null mutant IdrD-CTD39A, as well 5 as the negative control in which no IdrD-CT is present, showed little reduction in lambda DNA ( Fig. 1C ). Across all reactions, no apparent reduction in RNA occurred (Fig. S1C ). The IdrD-CT protein, but not the mutant protein, also degraded circular DNA ( Fig. S1D ). We concluded that the P. mirabilis IdrD-CT is capable of degrading both methylated and unmethylated DNA.
To examine whether IdrD-CT was produced in bacteria beyond P. mirabilis, we 10 conducted a phylogenetics screen for similar proteins. We identified 23 additional proteins through searches of UniProtKB and the NCBI draft and completed genomes using phmmer (24, 25) and tblastn (26, 27) . Each identified protein has the three conserved catalytic residues (D, D/E, K). Predicted secondary structures are consistent within these predicted proteins ( Fig. 1D ).
None of these IdrD-CT proteins belonged to known PD-(D/E)XK-containing families. 15 Given the sequence similarity, we queried whether these identified proteins also have DNA-degrading activity. We focused on a Rothia aeria protein as R. aeria are evolutionarily distant from P. mirabilis. R. aeria are Gram-positive inhabitants of the normal flora within the human oral cavity and pharynx (28) (29) (30) . Using the cell-free system, we produced the Rothia IdrD-CT protein, encoded by gene C6B_10599, and a predicted null mutant Rothia IdrD-CTD39A. 20 Each protein had a C-terminal FLAG epitope tag for detection. Samples with the Rothia IdrD-CT protein showed a loss of lambda DNA regardless of methylation state, while samples containing the Rothia IdrD-CTD39A protein or a negative control did not ( Fig. 1E, Fig. S1E ). There was no observable loss in RNA ( Fig. S1E ). Therefore, the Rothia IdrD-CT protein also degrades DNA.
Additional phylogenetic reconstruction of the identified proteins found representation across the bacterial tree ( Fig. S2A ). Protein sequences within a specific genus were more related than to those of different genera (Fig. S2A ). However, a species tree based on the full-length 16S 5 rRNA gene ( Fig. S2B ) revealed a discordant topology to the IdrD-CT tree ( Fig. S2A ). Proteins from evolutionarily distant bacteria appeared to share more similarity in sequence than with more closely related genera. Even with this topology, the Proteus and Rothia IdrD-CT proteins retained equivalent activities. We concluded that these IdrD-CT proteins, found across bacterial clades, form a distinct family of DNase proteins.
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IdrD-CT is modular and contains an interchangeable species-identifying domain.
In the sequence alignments of the identified proteins ( Fig. 1D ), the C-terminal region contained greater variability in amino acid composition across family members than the Nterminal region. We hypothesized that IdrD-CT proteins have two domains: one containing the 15 PD-(D/E)XK motif and one containing species-identifying information. Therefore, we made independent deletions of each domain in the P. mirabilis IdrD-CT protein and assayed for activity. Both deletion proteins resulted in no loss of lambda DNA ( Fig. 2A, Fig. S3A ).
Equivalent truncations of the Rothia IdrD-CT protein also showed no DNA degradation ( Fig.   S3B ). Therefore, both the enzymatic and species-identifying domains are essential for IdrD-CT 20 activity. The variation in the species-identifying domain hinted that the IdrD-CT protein might be modular. If so, then the species-identifying domain should be exchangeable among variants. To test this assertion, we swapped the 3' region, after the second predicted alpha-helix, between the IdrD-CT proteins of P. mirabilis and R. aeria. The hybrid IdrD-CT proteins degraded lambda DNA while the negative control did not ( Fig. 2B ). DNA degradation by these hybrid proteins 5 required more protein than the wild-type enzymes, indicating an attenuation in protein activity ( Fig. 2B ). As the IdrD-CT proteins are flexible in structural design and can tolerate large domain replacements, we reasoned that one could take advantage of the species-identifying sequences to detect distinct proteins in mixed-species communities.
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IdrD-CT proteins are present in human oral and gut microbiomes.
Genes specific to particular strains or species, such as IdrD-CT, could provide a means to identify low-abundance bacteria in deeply-sequenced datasets. Metagenomes are shotgun shortread sequencing of total DNA from a sample that capture a representation of microbial communities, or microbiomes. Bacteria at low abundance in these communities contribute little 15 DNA to the total and often remain hidden. Without sensitive detection methods, the roles and impacts of minority community members remain elusive, including how they defend their niches against more abundant neighbors.
Given the sequence diversity among the IdrD-CT proteins ( Fig. 1D ), we considered whether these proteins could be used to differentiate between high-and low-abundance bacteria 20 in naturally occurring mixed-species populations. To generate maximum diversity, we focused beyond the IdrD-CT protein and instead on the larger encoding gene. In many of the identified bacteria, including P. mirabilis (10), the IdrD-CT protein is encoded within the 3' end of the larger idrD gene (Fig. 3A ). Before proceeding with the analysis, we deployed an in silico test to examine whether seven reference idrD gene sequences are sufficiently distinct in nucleotide space to unambiguously identify even short fragments. Reference idrD sequences were from P. mirabilis BB2000, R. aeria C6B, Cronobacter turicensis z3032, Prevetolla jejuni CD3:33, Acinetobacter baumannii XH858, Pseudomonas fluorescens F113, and Xanthomonas citri pv. 5 malvacearum XcmN1003. We generated simulated metagenomes in silico from these seven idrD seed sequences under different sequencing and error rate scenarios and mapped these onto 127 different combinations of the idrD sequences. The mapping revealed no discernible fluctuations in coverage of hits ( Fig. S4 ), supporting that this method allows enough specificity to confidently distinguish between idrD sequences originating from different genera. 10 We next examined metagenomic datasets, capitalizing on the diversity in the nucleotide sequences. We mapped 319 high-quality metagenomes from the human gut or oral microbiomes, onto the idrD sequence with the highest sequence similarity from the pool of all seven reference idrD sequences ( Fig. 3B ). This competitive mapping approach maximizes specificity. Plotted on a resultant graph is the number of times a read mapped to a position in idrD, termed 'coverage' 15 ( Fig. 3B ). Each line is one metagenome. Smoothly decreasing coverage at the gene ends is an artifact of the mapping process (Supporting Fig. S4C ). Coverage otherwise reflects the proportional abundance of a region within the idrD gene in a single microbiome sample. We found that many of the sampled human microbiomes harbor the idrD gene. Fig. S5 ); we removed these organisms from further analysis. The idrD sequence of Prevotella was also present in oral metagenomes as expected given that the oral microbiota contains numerous Prevotella species. Therefore, this mapping reveals abundance and differentiates between genera.
The coverage mapping highlights domains within this gene. The idrD gene has two main regions, which is similar to the encoding genes for many polymorphic effectors (2, 33) . Starting metagenomes contained sequences for the IdrD-CT proteins. The exception is P. jejuni in which ~ 10% of microbiomes indicated the presence of genes encoding an IdrD-CT protein, suggesting that these proteins occur at low frequency in humans. Therefore, we conclude that multiple variants of idrD-like genes are present in microbiome samples, yet only a subset of these genes encode an IdrD-CT protein.
The coverage pattern for the P. jejuni IdrD-CT fell approximately halfway through the 5 encoding sequence, leading us to consider whether this pattern reflects true sequence variation among Prevotella species. The region containing the PD-(D/E)XK domain recruited reads abundantly from oral microbiomes, while the remainder of the sequence obtained comparably fewer reads ( Fig. 3D ). Given that P. jejuni was isolated from the human gut, we reasoned that the 3' region sequence within the gene encoding IdrD-CT could differ from that of Prevotella 10 species inhabiting the mouth. Therefore, we undertook an additional mapping analysis on the same oral metagenomes except using the nucleotide sequences of IdrD-CT from P. sp. C561 and P. fusca JCM 17724; both are isolates from the human oral cavity. P. sp. and P. fusca sequences received relatively even coverage across the entire sequence (Fig. 3E ). The P. jejuni sequence, which was added into the mapping analysis, again recruited little coverage in the 3' region of 15 IdrD-CT (Fig. 3E ). The 3' region of IdrD-CT thus reflects species diversity within the Prevotella genus.
Discussion
Effector families point to competitive strategies likely optimized for a particular niche or 20 community composition. Earlier metagenomic analysis on the abundance of cell-contact dependent toxic proteins, often originating from a single species, suggested that these effectors help establish dominance in a community and predicted niche-specific specialization of these proteins (8, 9) . Emerging is the possibility that genes in low-abundance and specific for species (or strains) could open a window for differentiating among bacterial populations within a complex community. To further address this hypothesis, the abundance of low-abundance species should be evaluated by incorporating greater resolution of species-identifying protein regions. 5 To this end, we have described IdrD-CT, a P. mirabilis self-recognition protein that acts on adjacent cells through direct contact (10). IdrD-CT is the founding member for a family of DNases; these proteins are modular and contain an interchangeable species-identifying domain.
We propose to term this family, "Idr-PDE-DNase." Through a combination of genetics and molecular biology along with biochemical and phylogenetic interrogation, we showed that IdrD- How gene clusters encoding strain-specific proteins (e.g., toxins or effectors) evolve is an intriguing question in multiple contexts. Two-pair toxic protein systems are analogous to colonization and addiction proteins or mating compatibility such as in Wolbachia (34) 
and in
Caenorhabditis elegans (35) . One current hypothesis is that speciation occurs on the gene cluster of the effector protein (toxin) and its immunity protein (anti-toxin), for example, through horizontal gene transfer, as these two-gene pairs are often in variable hotspots on the genome (2, 3, 7, 15) . Yet for these Idr-PDE-DNase proteins, a pair of domains within a protein follow such a 5 tandem pattern, raising the possibility that an evolutionary arms race, internal to the protein, may also drive speciation. Frequent horizontal gene transfer and/or shifting selection pressures could also explain the sequence variability within the Idr-PDE-DNase proteins.
Of the two essential domains of the Idr-PDE-DNase proteins, one has enzyme activity and is conserved, while the other is variable and contains information specific to genus and Figs. S1 to S5 Tables S1 to S2
Materials and Methods
Bacterial strains and media
Overnight cultures of all strains were grown aerobically at 37°C in LB broth. P. mirabilis strains were maintained on low swarming (LSW -) agar (10) and allowed to swarm on CM55 agar (blood agar base agar (Oxoid, Basing-stoke, England). E. coli strains were grown on 1.5% LB 5 agar. For plasmid maintenance, growth media had 35g/ml kanamycin. All strains are listed in Table S1 . Oligos used in this study are listed in Table S2 .
Strain construction
The PidrA-idrD expression plasmid was constructed by using polymerase chain reactions All plasmids were confirmed by Sanger sequencing (Genewiz). Plasmids with conjugative transfer elements, including all IdrD-CT expression plasmids, were moved into the 10 E. coli conjugative strain S17, which were then mated with recipient P. mirabilis strains. The presence of plasmids was confirmed in recipient strains by PCR using plasmid-specific primers.
Liquid viability assay
Overnight cultures of E. coli MG1655 carrying each expression plasmid were normalized 15 to an optical density at 595 nm (OD595) of 1.2 µL of normalized cultures was added to 198 µL of LB broth supplemented with kanamycin and 10 nM anhydrotetracycline and grown at 37°C for 16 hours in a 96 well-plate. OD595 readings were taken every half hour.
Microscopy 20 We performed microscopy on P. mirabilis strain BB2000 carrying either vector pBBR1-NheI (48) Reaction was then run on a 1% agarose gel for analysis.
Western blotting:
Samples were run on a 12% Tris-Tricine polyacrylamide gel, transferred to a nitrocellulose membrane, probed with rabbit anti-FLAG (1:4,000; Sigma-Aldrich, St. Louis, MO), then goat anti-rabbit conjugated to horseradish peroxidase (HRP) (1:5,000; KPL, Inc., 5 Gaithersburg, MD), and finally developed using Immun-Star HRP substrate kit (Bio-Rad Laboratories, Hercules, CA). Blots were visualized using a Chemidoc (Bio-Rad Laboratories, Hercules, CA) and TIFF files were used for analysis on Fiji (ImageJ, Madison, WI).
Identification of proteins with similarity to IdrD-CT 10
The amino acid sequence of Proteus IdrD-CT was used to search publicly available protein databases using phmmer (24, 25). Additionally, the nucleotide sequence of Proteus IdrD-CT was used to search against nucleotide sequence databases using tblastn (26, 27) . By hand, the amino acid sequences obtained from these searches were checked for the presence of the predicted active site residues and the absence of truncations compared to the Proteus IdrD-CT. The full C- 15 terminal domain was further determined by looking for an Rhs or VENN motif-containing domain, which marks the start of the C-terminal domain (2, 7, 15) . Alignments were of IdrD-CT and similar IdrD-CTs performed using MUSCLE followed by Ali2D on MPI Bioinformatics toolkit (23) 20 Phylogenetic reconstruction of idrD and species relationships
The amino acid sequences for 25 idrD genes identified as described above were obtained and aligned with muscle (49) before removing positions with less than 70% occupancy with trimAl (50). This alignment was passed to MrBayes v3.2.6 (51) to reconstruct the tree using the WAG substitution model (52) and gamma model of rate heterogeneity. Each run has 20 million generations sampled every 1,000 generations by four coupled chains heated at the default temperature of 0.2. Four independent runs were checked for convergence and then combined into a 50% majority rule tree after burning the initial 40% of the sampled trees. The species tree was 5 reconstructed using identical methods but with full-length 16S ribosomal RNA sequences obtained from the various genomes, choosing arbitrarily if multiple 16S rRNA copies were found in a genome. Specifically, alignment and MrBayes parameters were identical except for changing the model to GTR (53) . Maximum-likelihood trees were also generated with RAxML (54) using the appropriate WAG or GTR + gamma models and produced identical topologies, albeit with 10 less support (data not shown).
Metagenome selection and processing
A fully-reproducible workflow explaining and documenting commands and scripts used to perform the metagenome abundance is available at www.gibbslab.org on the Resources page. 15 Full-length idrD nucleotide sequences were obtained from Acinetobacter baumannii XH858, 17724, P. denticola NCTC 13067) along with the P. jejuni CD3:33 idrD sequence were mapped separately, using the same methods, mapping reads from 202 human oral cavity metagenomes.
In silico metagenome simulation Short-read metagenome sequences were simulated from all seven full-length idrD 20 reference nucleotide sequences with the ART simulator (Huang et al., 2012). We modeled two different scenarios; one based on using an Illumina HiSeq 2000 with 100x the normal error rate to sequence a metagenome to a depth of 30x with 25bp single-end reads short reads (Supplemental Figure S3 ). The other scenario (Supplemental Figure S3C ) was modeled with identical parameters except with the normal HS2000 error rate and paired-end 100bp reads. Each of the 127 different subset combinations of the seven full-length idrD reference sequences was used to create reference databases containing a different subset of available reference sequences, to which each artificially generated metagenome was mapped. Supplemental Figure S3 then 5 shows the coverage for each sequence (columns) for the different combination categories (rows).
Metagenome categorization
Metagenomes were binned into categories based on the provided "ScientificName" annotation. Metagenomes from the Human Microbiome Project (HMP) (58, 59) were listed as 10 "human metagenome"; these were disaggregated into "HMP oral metagenome" and "HMP gut metagenome" based on the sampled site listed in the "Analyte_Type" column. From the 1,188 metagenomes, we focused on only the 324 human oral or human gut metagenomes, defining human oral as metagenomes labelled "human oral metagenome", "HMP oral metagenome", or "Non-HMP oral metagenome" (n = 42) and human gut as metagenomes labelled "human gut 15 metagenome" or "human metagenome" (n = 277). Metagenomes annotated as "human metagenome" (n = 47) were categorized as human gut since though they originated from a variety of human body sites, the only three passing the filtration criteria (see next section) were from the human gut. Metagenomes annotated as "oral metagenome" (n = 112) were excluded as extremely low (single digit), noisy coverages were recovered. In addition, five metagenomes 20 were specifically discarded: SRR628272 was removed from all datasets as the original FASTQ mirabilis coverage that skewed the y-axis (>2,000x). 1,183 metagenomes remained after discarding these metagenomes, of which 319 were human oral or human gut metagenomes.
Moving forward, we focused exclusively on P. mirabilis, R. aeria, C. turicensis, and P. jejuni as 10 the other taxa's sequences had little to no coverage from the human metagenomes of interest.
Mapping filtration criteria
To minimize noisy coverage originating from metagenomes relevant for one organism but not another, we employed a filtering strategy that, for each idrD sequence, considered only 15 metagenomes from which at least half of the nucleotides received coverage. For Figures 4C and   4D , the filtering criterion was applied after subsetting to the C-terminal domain (CTD); that is, the filtration was applied based only on the CTD. The number of metagenomes passing the criterion is displayed in the top right corner of each subpanel in Figure 4 . For each metagenome passing the filtration step, each nucleotides' coverage is plotted as a partially-transparent line; 20 thus, metagenomes with similar coverage trends overlap and appear darker. Metagenome coverages inherently decrease smoothly towards the 3' and 5' ends of the gene because, moving towards the ends, the probability decreases that a short read will overlap enough of the reference sequence to be mapped there. 
